Girard Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $5.71M | Sell |
18,277
-229
| -1% | -$67.3K | 0.54% | 46 |
|
|
2024
Q1 | $5.26M | Sell |
18,506
-1,367
| -7% | -$400K | 0.5% | 48 |
|
|
2023
Q4 | $5.72M | Sell |
19,873
-846
| -4% | -$231K | 0.58% | 42 |
|
|
2023
Q3 | $5.57M | Sell |
20,719
-1,972
| -9% | -$492K | 0.63% | 37 |
|
|
2023
Q2 | $5.04M | Sell |
22,691
-23,625
| -51% | -$5.48M | 0.53% | 45 |
|
|
2023
Q1 | $11.2M | Buy |
46,316
+5,986
| +15% | +$1.47M | 1.24% | 19 |
|
|
2022
Q4 | $10.6M | Sell |
40,330
-493
| -1% | -$132K | 1.2% | 20 |
|
|
2022
Q3 | $9.2M | Sell |
40,823
-4,078
| -9% | -$988K | 1.22% | 18 |
|
|
2022
Q2 | $10.9M | Sell |
44,901
-3,176
| -7% | -$778K | 1.39% | 18 |
|
|
2022
Q1 | $11.6M | Buy |
48,077
+3,633
| +8% | +$835K | 1.27% | 18 |
|
|
2021
Q4 | $10M | Sell |
44,444
-1,988
| -4% | -$420K | 1.09% | 20 |
|
|
2021
Q3 | $9.87M | Buy |
46,432
+1,377
| +3% | +$317K | 1.25% | 18 |
|
|
2021
Q2 | $11M | Sell |
45,055
-2,200
| -5% | -$541K | 1.41% | 16 |
|
|
2021
Q1 | $11.8M | Buy |
47,255
+954
| +2% | +$228K | 1.7% | 11 |
|
|
2020
Q4 | $10.6M | Sell |
46,301
-1,582
| -3% | -$365K | 1.64% | 11 |
|
|
2020
Q3 | $12.2M | Buy |
47,883
+680
| +1% | +$168K | 2.04% | 9 |
|
|
2020
Q2 | $11.1M | Sell |
47,203
-1,740
| -4% | -$397K | 2.01% | 11 |
|
|
2020
Q1 | $9.92M | Buy |
48,943
+917
| +2% | +$200K | 1.98% | 11 |
|
|
2019
Q4 | $11.6M | Buy |
48,026
+444
| +0.9% | +$97.9K | 1.91% | 10 |
|
|
2019
Q3 | $9.21M | Sell |
47,582
-500
| -1% | -$96K | 1.71% | 14 |
|
|
2019
Q2 | $8.86M | Buy |
48,082
+5,247
| +12% | +$940K | 1.56% | 15 |
|
|
2019
Q1 | $8.14M | Buy |
42,835
+970
| +2% | +$185K | 1.52% | 17 |
|
|
2018
Q4 | $8.15M | Sell |
41,865
-2,284
| -5% | -$446K | 1.71% | 11 |
|
|
2018
Q3 | $9.15M | Sell |
44,149
-877
| -2% | -$173K | 1.62% | 10 |
|
|
2018
Q2 | $8.31M | Buy |
+45,026
| New | +$7.96M | 1.57% | 11 |
|
|
2018
Q1 | – | Sell |
-43,026
| Closed | -$7.48M | – | 254 |
|
|
2017
Q4 | $7.48M | Buy |
43,026
+2,190
| +5% | +$388K | 1.43% | 15 |
|
|
2017
Q3 | $7.61M | Buy |
40,836
+692
| +2% | +$123K | 1.57% | 11 |
|
|
2017
Q2 | $6.91M | Buy |
40,144
+5,792
| +17% | +$942K | 1.5% | 11 |
|
|
2017
Q1 | $5.64M | Buy |
34,352
+6,569
| +24% | +$1.09M | 1.36% | 14 |
|
|
2016
Q4 | $4.06M | Buy |
27,783
+1,472
| +6% | +$222K | 1.18% | 22 |
|
|
2016
Q3 | $4.39M | Buy |
26,311
+4,450
| +20% | +$753K | 1.46% | 13 |
|
|
2016
Q2 | $3.33M | Buy |
21,861
+7,149
| +49% | +$1.11M | 1.27% | 19 |
|
|
2016
Q1 | $2.21M | Buy |
14,712
+2,541
| +21% | +$378K | 0.96% | 35 |
|
|
2015
Q4 | $1.98M | Buy |
12,171
+4,651
| +62% | +$731K | 0.95% | 37 |
|
|
2015
Q3 | $1.04M | Buy |
7,520
+5,982
| +389% | +$943K | 0.59% | 59 |
|
|
2015
Q2 | $236K | Sell |
1,538
-65
| -4% | -$10.4K | 0.13% | 139 |
|
|
2015
Q1 | $256K | Buy |
+1,603
| New | +$252K | 0.15% | 124 |
|
|
2014
Q3 | – | Sell |
-1,738
| Closed | -$206K | – | 137 |
|
|
2014
Q2 | $206K | Buy |
+1,738
| New | +$201K | 0.14% | 130 |
|
Other funds holding AMGN
Girard Partners's AMGN Position: Q2 2024 in Review
Girard Partners reduced its Amgen (AMGN) stake by 1.2% in Q2 2024, selling an estimated $67.3K and leaving 18,277 shares worth $5.71M. The position accounts for 0.54% of the portfolio, ranked #46.
Girard Partners first reported a position in AMGN in Q2 2014 and has held it in 38 quarters since. The position peaked at $12.2M in Q3 2020. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Girard Partners held 18,277 shares of Amgen worth $5.71M as of Q2 2024.
- Girard Partners sold 229 Amgen shares in Q2 2024, an estimated $67.3K.
- Amgen made up 0.54% of Girard Partners's portfolio in Q2 2024, its #46 holding.
- Girard Partners first reported a position in Amgen in Q2 2014 and has held it in 38 quarters since.
- Girard Partners's Amgen position peaked at $12.2M in Q3 2020.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.